CYP3A7-CYP3A51P
MOLECULAR TARGETCYP3A7-CYP3A51P readthrough
CYP3A7-CYP3A51P (CYP3A7-CYP3A51P readthrough) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CYP3A7-CYP3A51P
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Ritonavir | 1.61 | 4 |
| 2 | Voriconazole | 1.39 | 3 |
About CYP3A7-CYP3A51P as a Drug Target
CYP3A7-CYP3A51P (CYP3A7-CYP3A51P readthrough) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented CYP3A7-CYP3A51P interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CYP3A7-CYP3A51P inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.